comparemela.com

Latest Breaking News On - Immunology research group - Page 3 : comparemela.com

Researchers discover unexpected blind spot of immune system

Researchers discover unexpected blind spot of immune system
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

A just vaccine roll-out, SA s school dropout rate and

The sixth World NGO Day will be commemorated on Saturday, 27 February in more than 89 countries. An NGO is non-profit and is run by citizens outside of any government structure. There are an estimated 10 million NGOs in the world, employing about 50 million people. The number of NGOs is expected to double in the next decade. The rest of the week… On Wednesday, 24 February, the digitalisation of South Africa’s social grant payments system will come under the spotlight. The Digital Welfare State and Human Rights Project will interview Lynette Maart, the director of Black Sash, on how it came to be that the country became dependent on just one company for the payment of grants. Listen in at 10am here. 

Dr Richard Woodman Appointed Chief Clinical Officer of the Oncology Business Group at Eisai Inc

Share this article WOODCLIFF LAKE, N.J., Jan. 20, 2021 /PRNewswire/  Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., today announces the immediate appointment of Dr. Richard Woodman as Chief Clinical Officer (CCLO) of its Oncology Business Group. In this role, Dr. Woodman will have full oversight and responsibility for the strategic and operational leadership of the company s global oncology clinical development functions, including clinical research, clinical operations, imaging, medical writing, data services, biostatistics and regulatory strategy. He will also serve as a member of the Oncology Executive Leadership team. Dr. Richard Woodman Dr. Woodman, who has 18 years of pharmaceutical experience in several different functional areas at both large and small biotech organizations, will lead the clinical team s development of Eisai s next generation oncology products by managing the design protocols and implementation of all oncology clinical trials. He w

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.